









市場
/
株式
/
nasdaq-dxcm
/

Dexcom Inc

DXCM

60.230USD

+1.810+3.10%

終値 11/21, 16:00（ET）15分遅れの株価

23.49B時価総額

32.59直近12ヶ月PER



Dexcom Inc

60.230

+1.810+3.10%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Dexcom Inc 企業名

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Dexcom Incの企業情報



企業コードDXCM

会社名Dexcom Inc

上場日Apr 14, 2005

最高経営責任者「CEO」Mr. Jacob Steven (Jake) Leach

従業員数10300

証券種類Ordinary Share

決算期末Apr 14

本社所在地6340 Sequence Dr

都市SAN DIEGO

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号92121

電話番号18582000200

ウェブサイトhttps://www.dexcom.com/

企業コードDXCM

上場日Apr 14, 2005

最高経営責任者「CEO」Mr. Jacob Steven (Jake) Leach

Dexcom Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

294.46K

+6.59%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

Ms. Bridgette P. Heller

Independent Director

27.03K

-3.61%

Mr. Kyle Malady

Independent Director

22.67K

-2.86%

Ms. Rimma Driscoll

Independent Director

9.04K

+127.87%

Ms. Renee D. Gala

Independent Director

6.88K

+20.30%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

294.46K

+6.59%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

地域別USD

会社名

収益

比率

United States

841.00M

72.68%

Outside of United states

316.10M

27.32%

事業別

地域別

事業別USD

会社名

収益

比率

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

株主

更新時刻: Tue, Nov 18

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

12.63%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

4.07%

Geode Capital Management, L.L.C.

2.81%

他の

69.92%

株主統計

比率

The Vanguard Group, Inc.

12.63%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

4.07%

Geode Capital Management, L.L.C.

2.81%

他の

69.92%

種類

株主統計

比率

Investment Advisor

53.29%

Investment Advisor/Hedge Fund

27.90%

Hedge Fund

7.32%

Research Firm

4.05%

Pension Fund

2.14%

Bank and Trust

1.93%

Sovereign Wealth Fund

1.61%

Venture Capital

0.48%

Individual Investor

0.37%

他の

0.93%

機関投資家保有株



更新時刻: Wed, Oct 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q3

2166

379.27M

97.24%

-45.06M

2025Q2

2212

390.97M

99.70%

-27.53M

2025Q1

2252

386.55M

98.59%

-25.17M

2024Q4

2220

380.88M

97.47%

-26.96M

2024Q3

2145

382.31M

97.83%

-30.58M

2024Q2

2115

397.02M

99.11%

-4.31M

2024Q1

2093

389.18M

98.33%

-19.87M

2023Q4

2081

398.01M

103.26%

+83.33K

2023Q3

1994

389.89M

100.89%

-11.88M

2023Q2

1952

389.17M

100.78%

-12.73M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

48.15M

12.28%

+859.71K

+1.82%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

24.25M

6.18%

-475.12K

-1.92%

Jun 30, 2025

State Street Investment Management (US)

16.86M

4.3%

+175.27K

+1.05%

Jun 30, 2025

Baillie Gifford & Co.

16.71M

4.26%

+2.53M

+17.81%

Jun 30, 2025

Geode Capital Management, L.L.C.

10.77M

2.75%

+358.62K

+3.45%

Jun 30, 2025

Jennison Associates LLC

11.52M

2.94%

+994.30K

+9.45%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

8.03M

2.05%

-28.35K

-0.35%

Aug 31, 2025

Nuveen LLC

7.30M

1.86%

-549.07K

-7.00%

Jun 30, 2025

MFS Investment Management

6.49M

1.65%

+3.30M

+103.55%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

Mar 28, 2022

Split

1→4

日付

種類

比率

Mar 28, 2022

Split

1→4

よくある質問

Dexcom Incの上位5名の株主は誰ですか？



Dexcom Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は48.15M株を保有しており、これは全体の12.28%に相当します。
BlackRock Institutional Trust Company, N.A.は24.25M株を保有しており、これは全体の6.18%に相当します。
State Street Investment Management (US)は16.86M株を保有しており、これは全体の4.30%に相当します。
Baillie Gifford & Co.は16.71M株を保有しており、これは全体の4.26%に相当します。
Geode Capital Management, L.L.C.は10.77M株を保有しており、これは全体の2.75%に相当します。